Attached files
| file | filename |
|---|---|
| 10-Q - 10-Q - ELITE PHARMACEUTICALS INC /NV/ | v193403_10q.htm |
| EX-31.1 - EX-31.1 - ELITE PHARMACEUTICALS INC /NV/ | v193403_ex31-1.htm |
| EX-32.2 - EX-32.2 - ELITE PHARMACEUTICALS INC /NV/ | v193403_ex32-2.htm |
| EX-31.2 - EX-31.2 - ELITE PHARMACEUTICALS INC /NV/ | v193403_ex31-2.htm |
Exhibit
32.1
CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002
In
connection with the Quarterly Report of Elite Pharmaceuticals, Inc. (the
“Registrant”) on Form 10-Q for the quarter ended June 30, 2010 filed with the
Securities and Exchange Commission (the “Report”), I, Jerry Treppel, Chief
Executive Officer of the Registrant, certify, pursuant to 18 U.S. C. Section
1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
that:
(1) The
Report fully complies with the requirements of Section 13(a) of the Securities
Exchange Act of 1934; and
(2) Information
contained in the Form 10-Q fairly presents, in all material respects, the
financial condition and results of operations of the
Registrant.
|
Date:
August 16,
2010
|
/s/ Jerry Treppel
|
||
|
Jerry
Treppel
|
|||
|
Chief
Executive Officer
|
|||
|
of
Elite Pharmaceuticals, Inc.
|
|||
|
(Principal
Executive Officer)
|
This
certification has been furnished solely pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002.
A signed
original of this written statement required by Section 906 has been provided to
Elite Pharmaceuticals, Inc. and will be retained by Elite Pharmaceuticals, Inc.
and furnished to the Securities and Exchange Commission or its staff upon
request.